Immune Evasion

免疫逃避

基本信息

  • 批准号:
    6747202
  • 负责人:
  • 金额:
    $ 0.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-02-01 至 2005-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infectious pathogens and tumors use many mechanisms to evade an immune response and survive in the organisms. Some of the same mechanisms are of relevance for the regulation of tolerance to self-antigens or its breakdown in autoimmunity. Their modulation may also result in successful graft take Infectious pathogens and tumors use many mechanisms to evade an immune response and survive in the organisms. Some of the same mechanisms are of relevance for the regulation of tolerance to self-antigens or its breakdown in autoimmunity. Their modulation may also result in successful graft take or rejection in organ transplantation. In the recent years there has been great progress in the understanding of many of these mechanisms that are very diverse but all result in the escape of the pathogen or tumor from an effective immune response with deleterious effect. Infectious disease immunity has been teaching us much about the mechanisms of immune evasion and what we have learned from these studies has greatly contributed to the understanding of cancer immune evasion and of the immunological mechanisms regulating autoimmunity and graft rejection. Because this meeting will be concurrent with a meeting on Microbial Latency (The Pathogen-Host Standoff: Persistent and Latent Infection), we have included only a limited number of presentations on immune evasion in infections (which is the major mechanism of microbial latency). The presentations on immunity to infections are limited to those fields (e.g. immunodeviation or oncogenic viruses) that provided important information for the understanding of the mechanisms of immune evasion. We have attempted to cover many aspects of immune evasion in cancer as well as to provide examples of the importance of similar mechanisms in autoimmunity, transplantation, and pregnancy.
描述(由申请人提供):感染性病原体和肿瘤使用许多机制来逃避免疫应答并在生物体中存活。一些相同的机制与调节对自身抗原的耐受性或其在自身免疫中的破坏有关。它们的调节也可能导致成功的移植,感染性病原体和肿瘤使用许多机制来逃避免疫反应并在生物体中存活。一些相同的机制与调节对自身抗原的耐受性或其在自身免疫中的破坏有关。它们的调节也可能导致器官移植中的成功移植或排斥。近年来,在理解这些机制中的许多机制方面取得了很大进展,这些机制非常多样,但都导致病原体或肿瘤从有效的免疫应答中逃逸,产生有害影响。传染病免疫已经教会了我们很多关于免疫逃避机制的知识,我们从这些研究中所学到的知识极大地促进了对癌症免疫逃避以及调节自身免疫和移植物排斥的免疫机制的理解。由于本次会议将与微生物潜伏期会议(病原体-宿主稳定性:持续性和潜伏性感染)同时举行,因此我们只包括了有限数量的关于感染中免疫逃避的演讲(这是微生物潜伏期的主要机制)。关于感染免疫的介绍仅限于那些为理解免疫逃避机制提供重要信息的领域(例如免疫偏离或致癌病毒)。我们试图涵盖癌症中免疫逃避的许多方面,并提供类似机制在自身免疫、移植和妊娠中的重要性的例子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GIORGIO TRINCHIERI其他文献

GIORGIO TRINCHIERI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GIORGIO TRINCHIERI', 18)}}的其他基金

Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
粪便微生物群移植和免疫检查点阻断治疗实体瘤
  • 批准号:
    10393924
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
粪便微生物群移植和免疫检查点阻断治疗实体瘤
  • 批准号:
    10650717
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6429977
  • 财政年份:
    2001
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6312712
  • 财政年份:
    2000
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6299940
  • 财政年份:
    2000
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6101449
  • 财政年份:
    1999
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6268605
  • 财政年份:
    1998
  • 资助金额:
    $ 0.8万
  • 项目类别:
CORE--FLOW CYTOMETRY FACILITY
核心——流式细胞仪
  • 批准号:
    6235998
  • 财政年份:
    1997
  • 资助金额:
    $ 0.8万
  • 项目类别:
IMMUNOBIOLOGY OF INTERLEUKIN 12
白细胞介素 12 的免疫生物学
  • 批准号:
    2653831
  • 财政年份:
    1994
  • 资助金额:
    $ 0.8万
  • 项目类别:
IMMUNOBIOLOGY OF INTERLUKIN-12
INTERLUKIN-12 的免疫生物学
  • 批准号:
    2761165
  • 财政年份:
    1994
  • 资助金额:
    $ 0.8万
  • 项目类别:

相似海外基金

Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
  • 批准号:
    10634775
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Mechanism of immune response to muscle-directed AAV gene transfer
肌肉定向 AAV 基因转移的免疫反应机制
  • 批准号:
    10717750
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
使用 IL-1R1 及其配体优化 T 细胞对癌症的免疫反应
  • 批准号:
    10801033
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
  • 批准号:
    10625948
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
  • 批准号:
    494926
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Operating Grants
Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines
改善基于纳米颗粒的 SARS-CoV-2 疫苗的免疫反应
  • 批准号:
    10648704
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Circadian Control of Brain-peripheral Immune Response After Stroke
中风后大脑周围免疫反应的昼夜节律控制
  • 批准号:
    10733910
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Immune response to MCMV infection in the salivary glands
唾液腺对 MCMV 感染的免疫反应
  • 批准号:
    10735748
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Spacer acquisition during the type III-A CRISPR-Cas immune response
III-A 型 CRISPR-Cas 免疫反应期间间隔区的获取
  • 批准号:
    10638980
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
The impact of gestational diabetes on Group B Streptococcal virulence and host immune response
妊娠糖尿病对 B 族链球菌毒力和宿主免疫反应的影响
  • 批准号:
    10738456
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了